Leisure Acquisition
Why Robinhood?
You can watch LACQ and buy or sell other stocks, ETFs, and their options commission-free!About LACQ
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses.
LACQ Key Statistics
Stock Snapshot
As of today, Leisure Acquisition(LACQ) shares are valued at $14.49. The company's market cap stands at 66.29M, with a P/E ratio of -0.13.
On 2026-03-31, Leisure Acquisition(LACQ) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Leisure Acquisition(LACQ) stock has reached 0, versus its average volume of 1.17M.
The stock's 52-week range extends from a low of $0.31 to a high of $4.85.
The stock's 52-week range extends from a low of $0.31 to a high of $4.85.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.